Half Dose of Prasugrel and Ticagrelor in Acute Coronary Syndrome (HOPE-TAILOR)

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 120 participants.

Also called NCT02944123

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 120 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02944123
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02944123. Randomized; single masking; primary purpose treatment. Start 2016-09 (actual); primary completion 2020-02 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Half Dose of Prasugrel and Ticagrelor in Acute Coronary Syndrome (HOPE-TAILOR)
Condition
Acute Coronary Syndrome
Intervention (Drug)
Clopidogrel 75 mg
Intervention (Drug)
Prasugrel 5 mg
Intervention (Drug)
Ticagrelor 45 mg
Lead sponsor
Dong-A University (class: other)

Record details

Record id
cardio:ct-nct02944123
Content hash
a1ec019b9954eee9796102e28e03ceb85f58a98868549500b2a3811b394de9ff